ClinicalTrials.gov
public full text
Public Domain
Efficacy and Safety of Clostridium Botulinum Toxin Type A to Improve Appearance of Moderate to Severe Glabellar Lines
The purpose of this study was to demonstrate the safety and the efficacy of a single treatment of an injectable liquid form of Clostridium botulinum toxin type A haemagglutinin complex (BTX-A-HAC; hereafter referred to as BTX-A-HAC Next Generation (BTX-A-HAC NG)), used for the improvement in the appearance of moderate to severe glabellar lines (the lines between the eyebrows).
Conceptio Open Archive
Analyze & explore related research in Conceptio
Connect this record directly into your research workflow or AI agent. Explore citations across open repositories, query full text, and export structured proof bundles.
This document is indexed with metadata only: full text is not available in the archive for this record. Open the official source ↗
Related documents
- Safety and Efficacy of BOTOX® (Botulinum Toxin Type A) in Korea#1161987
- Safety and Efficacy of Botulinum Toxin Type A Topical Gel for Lateral Canthal Lines#803351
- Botulinum Toxin A for the Treatment of Keratoconus#1030545
- Botulinum Toxin Type A in Treatment of Cranial Allodynia in Patients With Headache#1032989
- OnabotulinumtoxinA for the Treatment of New Daily Persistent Headache: an Open Label Study#1165247
Record · ID 873693
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Bring this data into your agent: Connect via MCP or API · 20 free credits to start · no card required
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive